APOE and atherosclerosis: TUDCA treatment alleviated aortic VSMC loss (Fig 4A and B), adventitial thickening (Fig 4C and D), and inhibited atherosclerosis (Fig 4E and F) in both Apoe−/−LmnaG609G/G609G and Apoe−/−LmnaLCS/LCSSM22αCre mice.